Nicole D. Perry is President & VP at Apellis Pharmaceuticals, Inc. (APLS). They have made 10 open-market trades across 1 company since 2020, most recently 2021-08-02.
CIK 0001657874
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APLS | 5,847 | $240K |
Shares reported on the most recent Form 4, priced at the 2021-08-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APLS | SELL | 2021-08-02 | 2021-08-03 | $63.99 | $64K | -8.7% | -0.5% | -48.4% |
| APLS | SELL | 2021-07-01 | 2021-07-02 | $64.00 | $64K | -9.5% | -8.6% | -52.4% |
| APLS | SELL | 2021-06-11 | 2021-06-15 | $61.56 | $62K | +5.5% | +4.8% | -46.1% |
| APLS | SELL | 2021-06-01 | 2021-06-02 | $56.40 | $56K | +17.6% | +26.6% | +19.3% |
| APLS | SELL | 2021-05-03 | 2021-05-04 | $50.73 | $51K | -11.0% | +12.4% | +27.1% |
| APLS | SELL | 2021-04-30 | 2021-05-03 | $50.00 | $50K | -8.3% | +12.8% | +27.1% |
| APLS | SELL | 2021-03-01 | 2021-03-03 | $50.00 | $100K | +4.6% | -4.7% | +28.7% |
| APLS | SELL | 2021-02-09 | 2021-02-10 | $50.00 | $100K | -4.9% | -3.5% | -3.5% |
| APLS | SELL | 2021-01-04 | 2021-01-05 | $57.24 | $114K | -5.1% | -16.6% | -22.2% |
| APLS | SELL | 2020-12-04 | 2020-12-08 | $50.00 | $900K | +0.9% | +4.6% | -11.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.